Enterprise Financial Services Corp Bio Rad Laboratories, Inc. Transaction History

Enterprise Financial Services Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $55,247 - $69,364	-84 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$547.01 - $662.35 $2,735 - $3,311	-5 Reduced 5.62%	84 $48,000
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $2,553 - $3,217	5 Added 5.95%	89 $52,000
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $9,543 - $11,247	21 Added 33.33%	84 $43,000
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $3,520 - $4,499	11 Added 21.15%	63 $22,000
Q3 2017 Oct 27, 2017	BUY	$212.27 - $242.28 $11,038 - $12,598	52	52 $12,000

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.48B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.